Top Markets
#1 Black Phoenix Black Phoenix +324.80%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +57.52%
#4 Gold Park Gold Park +55.04%
#5 Acurast Acurast +30.18%
#6 BasedHype BasedHype +28.28%
#7 Cryptopia Cryptopia +22.67%
#8 Avantis Avantis +19.62%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.72%
#10 MYX Finance MYX Finance +16.77%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Baseline Productions, Inc. Baseline Productions, Inc.

Baseline Productions, Inc.

BSSP
Rank in Stocks #40835
As of 2021, Baseline Productions, Inc. is actively pursuing opportunities for a... As of 2021, Baseline Productions, Inc. is actively pursuing opportunities for a merger or acquisition. Simultaneously, the company is working to bring its operations and status up-to-date. This strategic shift follows a significant development on October 9, 2017, when its Pharmaceutical Services Agreement (PSA) with Canteck Pharma, Inc. was terminated. The reason for this termination was the company's inability to secure the necessary licensing to proceed with its immunotherapeutic-based technology, which was specifically targeted at cancer indications, within Mexico.
Share Price
$0.0002
Last synced: 2026-08-12
Market Cap
$74.38K
Change (1 day)
0.00%
Change (1 year)
100.00%
Country
US
Trade Baseline Productions, Inc. (BSSP)

Category

Healthcare
Earnings for Baseline Productions, Inc. (BSSP)
Earnings in 2026 TTM: 0
According to Baseline Productions, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Baseline Productions, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE